Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Campaigners dismayed at unworkable partial smoking ban

October 28, 2005 Research and Development

Doctors and health campaigners have expressed their deep disappointment over the government's failure to introduce a complete smoking ban in …
News

Oxford BioMedica’s lung cancer candidate shows promise

October 25, 2005 Research and Development

A promising antibody developed by UK-based Oxford BioMedica is poised to enter clinical trials to treat lung cancer.The 5T4 antibody-targeted …
News

Blockbuster partnerships

October 21, 2005 Research and Development

Since pharma'ps big wave of innovation during the early 1990s, peaking in 1996 when 131 new drug applications were filed …
Feature

Merck to co-develop novel prostate cancer candidate

October 18, 2005 Research and Development

Merck is to develop a new monoclonal antibody which has shown promise in treating prostate cancer.The US company has signed …
News

Winning CROs look east for expansion

October 18, 2005 Research and Development

The new onus on outsourcing has seen CROs reap the benefits of an industry striving to cut resource investment while …
Feature

Genzyme opens first European research centre in Cambridge

September 30, 2005 Research and Development

Genzyme, one of the most successful US biotech companies, has opened its first European research centre in Cambridge, UK – …
News

The inspector calls

September 28, 2005 Research and Development

I have become a pharmacovigilance bore within my company, a prophet of doom. It is worse than that, because for …
Feature
Sains

Lilly increasing investment in UK R&D

September 23, 2005 Research and Development

 Lilly has opened a new  £26 million UK research facility, a move which underlines its commitment to developing medicines in …
News

Novartis pipeline promises cardiovascular advances

September 22, 2005 Research and Development

Novartis hopes to expand its presence in cardiovascular medicine with the filing next year of two potentially first-in-class products with …
News

NICE to review guidance on hypertension treatments

September 22, 2005 Research and Development

NICE has set up a specialist advisory group to review new data which could lead to thousands of heart patients …
News

Exubera receives FDA vote of confidence

September 9, 2005 Research and Development, Sales and Marketing

Exubera, the first inhaled insulin treatment for diabetes, has moved a step closer to US approval following recommendation approval from …
News

GSK acquires vaccines research and manufacturing facility

September 8, 2005 Manufacturing and Production, Research and Development

GlaxoSmithKline has acquired a vaccines R&D and manufacturing facility in the US, which it will use to develop its next …
News

Scientists back testing after guinea pig breeder forced to close

September 6, 2005 Research and Development

UK scientists have rallied to support animal research after a six-year campaign against Staffordshire guinea pig breeder Darley Oaks Farm …
News

Takeda’s dependence-free sleeping pill approved

September 2, 2005 Research and Development, Sales and Marketing

A new sleeping pill which patients cannot abuse or become dependent on has been approved in the US.Takeda's Rozerem (ramelteon) …
News

Pfizer acquires antibody optimisation company

August 17, 2005 Research and Development

Pfizer has purchased a company that develops technology to optimise antibodies to help it identify and develop new drugs with …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026